Alta Fundamental Advisers LLC Neoleukin Therapeutics, Inc. Transaction History

Alta Fundamental Advisers LLC

  • $226 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.68 - $0.91 $60,997 - $81,628
89,702 New
89,702 $74,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Alta Fundamental Advisers LLC Portfolio

Follow Alta Fundamental Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Fundamental Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alta Fundamental Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email